Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing

被引:40
|
作者
Voigt, Tilman [2 ]
Meyer, Kathrin [1 ]
Baum, Oliver [2 ]
Schuemperli, Daniel [1 ]
机构
[1] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland
[2] Univ Bern, Inst Anat, CH-3012 Bern, Switzerland
基金
瑞士国家科学基金会;
关键词
Spinal Muscular Atrophy; Neuromuscular junctions; Diaphragm; Perisynaptic Schwann cells; Mouse models; MOTOR END-PLATE; PERISYNAPTIC SCHWANN-CELLS; DETERMINING GENE-PRODUCT; MESSENGER-RNA; NEURON GENE; SURVIVAL; COMPLEX; PROTEIN; MATURATION; MICE;
D O I
10.1016/j.nmd.2010.06.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In Spinal Muscular Atrophy (SMA), the SMN1 gene is deleted or inactivated. Because of a splicing problem, the second copy gene, SMN2, generates insufficient amounts of functional SMN protein, leading to the death of spinal cord motoneurons. For a "severe" mouse SMA model (Smn-/-, hSMN2 +/+; with affected pups dying at 5-7 days), which most closely mimicks the genetic set-up in human SMA patients, we characterise SMA-related ultrastructural changes in neuromuscular junctions (NMJs) of two striated muscles with discrete functions. In the diaphragm, but not the soleus muscle of 4-days old SMA mice, mitochondria on both sides of the NMJs degenerate, and perisynaptic Schwann cells as well as endoneurial fibroblasts show striking changes in morphology. Importantly, NMJs of SMA mice in which a modified U7 snRNA corrects SMN2 splicing and delays or prevents SMA symptoms are normal. This ultrastructural study reveals novel features of NMJ alterations - in particular the involvement of perisynaptic Schwann cells - that may be relevant for human SMA pathogenesis. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:744 / 752
页数:9
相关论文
共 19 条
  • [1] Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing
    Odermatt, Philipp
    Trub, Judith
    Furrer, Lavinia
    Fricker, Roger
    Marti, Andreas
    Schumperli, Daniel
    MOLECULAR THERAPY, 2016, 24 (10) : 1797 - 1805
  • [2] Spinal muscular atrophy:: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence
    Marquis, Julien
    Meyer, Kathrin
    Angehrn, Larissa
    Kaempfer, Sacha S.
    Rothen-Rutishauser, Barbara
    Schuemperli, Daniel
    MOLECULAR THERAPY, 2007, 15 (08) : 1479 - 1486
  • [3] Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation
    Meyer, Kathrin
    Marquis, Julien
    Trueb, Judith
    Nlend, Rachel Nlend
    Verp, Sonia
    Ruepp, Marc-David
    Imboden, Hans
    Barde, Isabelle
    Trono, Didier
    Schuemperli, Daniel
    HUMAN MOLECULAR GENETICS, 2009, 18 (03) : 546 - 555
  • [4] Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2
    Cartegni, L
    Hastings, ML
    Calarco, JA
    de Stanchina, E
    Krainer, AR
    AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 78 (01) : 63 - 77
  • [5] A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
    Kashima, T
    Manley, JL
    NATURE GENETICS, 2003, 34 (04) : 460 - 463
  • [6] Tetracyclines That Promote SMN2 Exon 7 Splicing as Therapeutics for Spinal Muscular Atrophy
    Hastings, Michelle L.
    Berniac, Joel
    Liu, Ying Hsiu
    Abato, Paul
    Jodelka, Francine M.
    Barthel, Lea
    Kumar, Sujatha
    Dudley, Caroline
    Nelson, Mark
    Larson, Kelley
    Edmonds, Jason
    Bowser, Todd
    Draper, Michael
    Higgins, Paul
    Krainer, Adrian R.
    SCIENCE TRANSLATIONAL MEDICINE, 2009, 1 (05)
  • [7] A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
    Tsuyoshi Kashima
    James L Manley
    Nature Genetics, 2003, 34 : 460 - 463
  • [8] Correcting SMN2 splicing with tailed antisense oligoribonucleotides: a promising therapeutic strategy for spinal muscular atrophy
    Zhou, H.
    Owen, N.
    Eperon, I. C.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 578 - 578
  • [9] Spinal muscular atrophy A new player joins the battle for SMN2 exon 7 splicing
    Pedrotti, Simona
    Sette, Claudio
    CELL CYCLE, 2010, 9 (19) : 3874 - 3879
  • [10] A SMN2 Splicing Modifier Rescues the Disease Phenotypes in an In Vitro Human Spinal Muscular Atrophy Model
    Son, Ye Seul
    Choi, Kwangman
    Lee, Hana
    Kwon, Ohman
    Jung, Kwang Bo
    Cho, Sunwha
    Baek, Jiyeon
    Son, Bora
    Kang, Sung-Min
    Kang, Mingu
    Yoon, Jihee
    Shen, Haihong
    Lee, Sangku
    Oh, Jung-Hwa
    Lee, Hyang-Ae
    Lee, Mi-Ok
    Cho, Hyun-Soo
    Jung, Cho-Rok
    Kim, Janghwan
    Cho, Sungchan
    Son, Mi-Young
    STEM CELLS AND DEVELOPMENT, 2019, 28 (07) : 438 - 453